Docmode Health Technologies Limited

Docmode Health Technologies IPO

Docmode Health Technologies Limited

₹1,26,400 /1600 sharesMinimum investment

IPO details

Minimum investment
₹1,26,400
Price range
₹79 - ₹79
Lot size
1,600
Issue size
6.71 Cr
Face value
10
IPO document

Subscription rate

Data will be available soon

Schedule

25 Jan 2024
IPO open date
30 Jan 2024
IPO close date
31 Jan 2024
Allotment date
31 Jan 2024
Funds unblock or debit
2 Feb 2024
Tentative listing date

About

Docmode Health Technologies offers learning and reference solutions for healthcare professionals and trainees globally. They provide online as well as offline learning models and support. The offline approach includes conferences and workshops, while the online platform features content developed by the in-house team or medical institutions, associations, and subject matter experts. The online learning module includes notes, recorded videos, live conferences, and workshops. The company also facilitates inter-professional cross-industry learning through panel discussions and courses. Additionally, healthcare professionals can enhance their clinical acumen using performance assessment tools provided by the company.;
Founded in
2017
MD/CEO
Mr. Paulson Paul Thazhathedath
Parent organisation
Docmode Health Technologies Limited

Docmode Health Technologies Financials

Revenue
Total Assets
Profit
All values are in ₹ Cr
7.1012.4232.88202120222023

Strengths & Risks

Strengths
Risks
The company utilizes cutting-edge technology to provide digital courses, fostering self-paced learning for healthcare professionals and learners. With a repository of digital content and study materials stored in cloud-based labs, accessibility is global without geographical constraints.
The company benefits from strong network effects across various medical specialities, connecting general practitioners, consultants, super specialists, healthcare professionals, patients, and medical learners. This interconnected ecosystem contributes to the growth of Docmode Health Technologies.
Backed by a team of experienced professionals and experts from diverse medical specialties on the scientific advisory board, the company thrives on its education, business experience and professionally qualified human capital. This expertise guides the creation of learning programs, identifies education gaps, updates team members, and collaborates with institutions for endorsements.
Docmode Health Technologies offers diversified and integrated education products, services, and content. From CME courses to live lecture series and workshops in collaboration with medical institutions and associations, the company's broad spectrum of services provides a competitive edge.
The commitment to continuous improvement is evident through the addition of new courses based on emerging trends. With 87 certificate programs and collaborations with 35+ medical associations globally, the company focuses on updating, upskilling, and reskilling courses for learners and healthcare professionals.
Docmode Health Technologies relies on its relationships with healthcare professionals, and any inability to engage them regularly may impact its business and financial results.
Disruptions in the company's information technology systems could have adverse effects on its business, operations, and prospects.
The subsidiary company of Docmode Health Technologies has incurred losses in the past, and there is no guarantee that it won't face losses in the future, potentially affecting the company's reputation and business.
Docmode Health Technologies depends on affiliated medical institutions for its business, and any reduction or interruption in a key medical institution may adversely impact the company's revenues and operations.
The company has availed unsecured loans amounting to Rs. 4.72 crores, and there is a risk that private lenders may recall these loans at any time. This could result in insufficient working capital for timely payments.
Docmode Health Technologies also has unsecured loans with banks and financial institutions that are repayable on demand. Any demand for repayment may affect the company's cash flow and financial condition, with a total outstanding of Rs. 8.1108 crores as of September 30, 2023.

Application details

For Docmode Health Technologies IPO, eligible investors can apply as Regular.

Apply asPrice bandApply rangeLot size
Regular₹79 - ₹79₹2 - ₹5 Lakhs1600
High Networth Individual₹79 - ₹79₹2 - ₹5 Lakhs1600

Frequently Asked Questions